Halozyme Therapeutics Inc (HALO) — Cash Flow-to-Debt Ratio
Halozyme Therapeutics Inc (HALO) has a Cash Flow-to-Debt Ratio of 0.10x as of September 2025, meaning its operating cash flow of $178.60 Million could theoretically repay 0% of its total liabilities ($1.72 Billion) in one year. See HALO FCF generation index to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Halozyme Therapeutics Inc Cash Flow-to-Debt Ratio (2001–2024)
Historical debt coverage capacity for Halozyme Therapeutics Inc across 24 annual periods. Also explore Halozyme Therapeutics Inc annual equity growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Halozyme Therapeutics Inc (2001–2024)
Year-by-year debt coverage analysis for Halozyme Therapeutics Inc. For market capitalisation and broader financial context, see Halozyme Therapeutics Inc (HALO) total market value.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.28x | $479.06 Million | $1.70 Billion | ▲ +19.6% |
| 2023 | 0.24x | $388.57 Million | $1.65 Billion | ▲ +64.0% |
| 2022 | 0.14x | $240.11 Million | $1.67 Billion | ▼ -56.5% |
| 2021 | 0.33x | $299.44 Million | $907.48 Million | ▲ +155.2% |
| 2020 | 0.13x | $55.45 Million | $428.88 Million | ▲ +171.8% |
| 2019 | -0.18x | $-85.42 Million | $474.11 Million | ▲ +30.3% |
| 2018 | -0.26x | $-49.50 Million | $191.36 Million | ▼ -160.1% |
| 2017 | 0.43x | $134.05 Million | $311.58 Million | ▲ +351.1% |
| 2016 | -0.17x | $-50.38 Million | $294.00 Million | ▲ +35.9% |
| 2015 | -0.27x | $-37.08 Million | $138.79 Million | ▲ +29.9% |
| 2014 | -0.38x | $-47.52 Million | $124.62 Million | ▲ +5.9% |
| 2013 | -0.41x | $-49.34 Million | $121.78 Million | ▲ +45.9% |
| 2012 | -0.75x | $-64.33 Million | $85.87 Million | ▼ -19.6% |
| 2011 | -0.63x | $-34.35 Million | $54.86 Million | ▲ +2.1% |
| 2010 | -0.64x | $-45.39 Million | $70.99 Million | ▼ -11.9% |
| 2009 | -0.57x | $-40.15 Million | $70.25 Million | ▲ +1.1% |
| 2008 | -0.58x | $-35.37 Million | $61.18 Million | ▼ -17791.0% |
| 2007 | 0.00x | $-147.66K | $45.69 Million | ▼ -101.1% |
| 2006 | 0.31x | $7.08 Million | $23.01 Million | ▲ +105.5% |
| 2005 | -5.64x | $-13.00 Million | $2.30 Million | ▼ -15.5% |
| 2004 | -4.89x | $-7.72 Million | $1.58 Million | ▼ -268.0% |
| 2003 | -1.33x | $-49.73K | $37.45K | ▲ +75.2% |
| 2002 | -5.35x | $-55.78K | $10.43K | ▲ +48.8% |
| 2001 | -10.45x | $-34.37K | $3.29K | — |